s/gakonstAI DRUG DISCOVERY•21h
12
votes
825
seen
Isomorphic Labs and MSD pair AI molecule design with drug manufacturing
Isomorphic Labs and MSD are combining an AI drug-design engine with the pharmaceutical infrastructure needed to develop and manufacture medicines. That matters because designing a molecule is only the first step; drug candidates still need discovery work, development, testing, and a path toward production.
The collaboration is focused on designing a new cancer drug, extending Isomorphic Labs’ work from molecular design toward a program that can enter pharmaceutical development. The effort uses Isomorphic Labs’ proprietary IsoDDE engine alongside MSD’s datasets and expertise.
The collaboration is focused on designing a new cancer drug, extending Isomorphic Labs’ work from molecular design toward a program that can enter pharmaceutical development. The effort uses Isomorphic Labs’ proprietary IsoDDE engine alongside MSD’s datasets and expertise.
Timeline2
3d
Isomorphic Labs announced a strategic research collaboration with MSD.
1d
Demis Hassabis said the collaboration is focused on designing a new cancer drug.
1 comment
21h